Reactive astrocyte nomenclature, definitions, and future directions
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Reactive astrocyte nomenclature, definitions, and future directions. / Escartin, Carole; Galea, Elena; Lakatos, Andras; O'Callaghan, James P.; Petzold, Gabor C.; Serrano-Pozo, Alberto; Steinhauser, Christian; Volterra, Andrea; Carmignoto, Giorgio; Agarwal, Amit; Allen, Nicola J.; Araque, Alfonso; Barbeito, Luis; Barzilai, Ari; Bergles, Dwight E.; Bonvento, Gilles; Butt, Arthur M.; Chen, Wei-Ting; Cohen-Salmon, Martine; Cunningham, Colm; Deneen, Benjamin; De Strooper, Bart; Diaz-Castro, Blanca; Farina, Cinthia; Freeman, Marc; Gallo, Vittorio; Goldman, James E.; Goldman, Steven A.; Gotz, Magdalena; Gutierrez, Antonia; Haydon, Philip G.; Heiland, Dieter H.; Hol, Elly M.; Holt, Matthew G.; Iino, Masamitsu; Kastanenka, Ksenia V.; Kettenmann, Helmut; Khakh, Baljit S.; Koizumi, Schuichi; Lee, C. Justin; Liddelow, Shane A.; MacVicar, Brian A.; Magistretti, Pierre; Messing, Albee; Mishra, Anusha; Molofsky, Anna V.; Murai, Keith K.; Norris, Christopher M.; Okada, Seiji; Oliet, Stephane H. R.; Oliveira, Joao F.; Panatier, Aude; Parpura, Vladimir; Pekna, Marcela; Pekny, Milos; Pellerin, Luc; Perea, Gertrudis; Perez-Nievas, Beatriz G.; Pfrieger, Frank W.; Poskanzer, Kira E.; Quintana, Francisco J.; Ransohoff, Richard M.; Riquelme-Perez, Miriam; Robel, Stefanie; Rose, Christine R.; Rothstein, Jeffrey D.; Rouach, Nathalie; Rowitch, David H.; Semyanov, Alexey; Sirko, Swetlana; Sontheimer, Harald; Swanson, Raymond A.; Vitorica, Javier; Wanner, Ina-Beate; Wood, Levi B.; Wu, Jiaqian; Zheng, Binhai; Zimmer, Eduardo R.; Zorec, Robert; Sofroniew, Michael V.; Verkhratsky, Alexei.
In: Nature Neuroscience, Vol. 24, 2021, p. 312–325.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Reactive astrocyte nomenclature, definitions, and future directions
AU - Escartin, Carole
AU - Galea, Elena
AU - Lakatos, Andras
AU - O'Callaghan, James P.
AU - Petzold, Gabor C.
AU - Serrano-Pozo, Alberto
AU - Steinhauser, Christian
AU - Volterra, Andrea
AU - Carmignoto, Giorgio
AU - Agarwal, Amit
AU - Allen, Nicola J.
AU - Araque, Alfonso
AU - Barbeito, Luis
AU - Barzilai, Ari
AU - Bergles, Dwight E.
AU - Bonvento, Gilles
AU - Butt, Arthur M.
AU - Chen, Wei-Ting
AU - Cohen-Salmon, Martine
AU - Cunningham, Colm
AU - Deneen, Benjamin
AU - De Strooper, Bart
AU - Diaz-Castro, Blanca
AU - Farina, Cinthia
AU - Freeman, Marc
AU - Gallo, Vittorio
AU - Goldman, James E.
AU - Goldman, Steven A.
AU - Gotz, Magdalena
AU - Gutierrez, Antonia
AU - Haydon, Philip G.
AU - Heiland, Dieter H.
AU - Hol, Elly M.
AU - Holt, Matthew G.
AU - Iino, Masamitsu
AU - Kastanenka, Ksenia V.
AU - Kettenmann, Helmut
AU - Khakh, Baljit S.
AU - Koizumi, Schuichi
AU - Lee, C. Justin
AU - Liddelow, Shane A.
AU - MacVicar, Brian A.
AU - Magistretti, Pierre
AU - Messing, Albee
AU - Mishra, Anusha
AU - Molofsky, Anna V.
AU - Murai, Keith K.
AU - Norris, Christopher M.
AU - Okada, Seiji
AU - Oliet, Stephane H. R.
AU - Oliveira, Joao F.
AU - Panatier, Aude
AU - Parpura, Vladimir
AU - Pekna, Marcela
AU - Pekny, Milos
AU - Pellerin, Luc
AU - Perea, Gertrudis
AU - Perez-Nievas, Beatriz G.
AU - Pfrieger, Frank W.
AU - Poskanzer, Kira E.
AU - Quintana, Francisco J.
AU - Ransohoff, Richard M.
AU - Riquelme-Perez, Miriam
AU - Robel, Stefanie
AU - Rose, Christine R.
AU - Rothstein, Jeffrey D.
AU - Rouach, Nathalie
AU - Rowitch, David H.
AU - Semyanov, Alexey
AU - Sirko, Swetlana
AU - Sontheimer, Harald
AU - Swanson, Raymond A.
AU - Vitorica, Javier
AU - Wanner, Ina-Beate
AU - Wood, Levi B.
AU - Wu, Jiaqian
AU - Zheng, Binhai
AU - Zimmer, Eduardo R.
AU - Zorec, Robert
AU - Sofroniew, Michael V.
AU - Verkhratsky, Alexei
PY - 2021
Y1 - 2021
N2 - Reactive astrocytes are astrocytes undergoing morphological, molecular, and functional remodeling in response to injury, disease, or infection of the CNS. Although this remodeling was first described over a century ago, uncertainties and controversies remain regarding the contribution of reactive astrocytes to CNS diseases, repair, and aging. It is also unclear whether fixed categories of reactive astrocytes exist and, if so, how to identify them. We point out the shortcomings of binary divisions of reactive astrocytes into good-vs-bad, neurotoxic-vs-neuroprotective or A1-vs-A2. We advocate, instead, that research on reactive astrocytes include assessment of multiple molecular and functional parameters-preferably in vivo-plus multivariate statistics and determination of impact on pathological hallmarks in relevant models. These guidelines may spur the discovery of astrocyte-based biomarkers as well as astrocyte-targeting therapies that abrogate detrimental actions of reactive astrocytes, potentiate their neuro- and glioprotective actions, and restore or augment their homeostatic, modulatory, and defensive functions.Good-bad binary classifications fail to describe reactive astrocytes in CNS disorders. Here, 81 researchers reach consensus on widespread misconceptions and provide definitions and recommendations for future research on reactive astrocytes.
AB - Reactive astrocytes are astrocytes undergoing morphological, molecular, and functional remodeling in response to injury, disease, or infection of the CNS. Although this remodeling was first described over a century ago, uncertainties and controversies remain regarding the contribution of reactive astrocytes to CNS diseases, repair, and aging. It is also unclear whether fixed categories of reactive astrocytes exist and, if so, how to identify them. We point out the shortcomings of binary divisions of reactive astrocytes into good-vs-bad, neurotoxic-vs-neuroprotective or A1-vs-A2. We advocate, instead, that research on reactive astrocytes include assessment of multiple molecular and functional parameters-preferably in vivo-plus multivariate statistics and determination of impact on pathological hallmarks in relevant models. These guidelines may spur the discovery of astrocyte-based biomarkers as well as astrocyte-targeting therapies that abrogate detrimental actions of reactive astrocytes, potentiate their neuro- and glioprotective actions, and restore or augment their homeostatic, modulatory, and defensive functions.Good-bad binary classifications fail to describe reactive astrocytes in CNS disorders. Here, 81 researchers reach consensus on widespread misconceptions and provide definitions and recommendations for future research on reactive astrocytes.
U2 - 10.1038/s41593-020-00783-4
DO - 10.1038/s41593-020-00783-4
M3 - Journal article
C2 - 33589835
VL - 24
SP - 312
EP - 325
JO - Nature Neuroscience
JF - Nature Neuroscience
SN - 1097-6256
ER -
ID: 257781932